AzTrials
AzTrials

Asthma in ChildrenNCT03317977

Translating an Efficacious Illness Management Intervention for Youth With Asthma

A study testing MATCH in people with Asthma in Children, run by Wayne State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The propose of the study is to test the effectiveness of Reach for Control (RFC) as compared to Michigan MATCH to improve asthma symptoms, asthma management and lung functioning and to decrease ED visits and admissions for youth with poorly controlled asthma when integrated into hospital emergency departments and… Read more about this study

Who is it for?
Ages 12 to 16 years
Conditions the study is for
Asthma in Children
What is being tested?
MATCH
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteUnited States
Study dates
1 Feb 2018to 8 Aug 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Adolescent/Parent:
  • Child aged 12 years, 0 months to 16 years, 11 months
  • Moderate to severe persistent asthma
  • Child seen in the CHM emergency department for treatment of asthma exacerbation
  • Child has experienced 2 or more ED visits and/ or inpatient admissions in prior 12 months (i.e. poorly controlled asthma)
  • Parent/ legal guardian willing to participate in home-based family treatment
  • Child and family resides within 20 miles of CHM (allows for home-based data collection and intervention)

Who cannot join

  • Adolescent/Parent:
  • Child is currently in an out-of-home placement
  • Schizophrenia or other psychosis on the part of the youth or parent
  • Current suicidality or homicidality on the part of the youth or parent
  • Cognitive impairment or learning disability that prevents comprehension of research measures on the part of parent or youth

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital of Michigan

    Detroit, Michigan, 48201

Other trials in United States

About this study

Official title: Translating an Efficacious Illness Management Intervention for Youth With Poorly Controlled Asthma to Real World Settings

The propose of the study is to test the effectiveness of Reach for Control (RFC) as compared to Michigan MATCH to improve asthma symptoms, asthma management and lung functioning and to decrease ED visits and admissions for youth with poorly controlled asthma when integrated into hospital emergency departments and delivered by community health workers. The study is a hybrid implementation-effectiveness design and will test RFC for use in real world, public healthcare settings.

Read the detailed description

The study was conducted in the emergency department at Children's Hospital of Michigan; CHM). 170 adolescents with poorly controlled asthma and their primary caregivers will be enrolled. Prior to the COVID-19 pandemic, families were randomly assigned to six months of home-based family treatment consisting of either RFC or Michigan MATCH , a model program endorsed by the State of Michigan for treatment of poorly controlled asthma. Subsequently, all intervention content in both arms was delivered by telehealth. Treatment content of RFC consists of weekly sessions focusing on asthma education, asthma management skills, improving home-school community for asthma, access to care and case management. MATCH includes asthma education but is less intensive and does not focus on family management skills. Treatment was provided by community health workers (CHWs) employed by a community agency providing MATCH as their standard of care. Consent and data collection was completed at baseline with additional data collection visits at 6, 12 and 18 months after baseline. Data collection was completed by project research assistants and consists of questionnaires and interviews with the adolescent and parent to assess asthma management, asthma symptoms and hospital utilization. The data analyses were intent-to-treat, meaning that all randomized participants are included regardless of the intervention dose received. Trial data were analyzed using linear mixed effect models.

Being tested
Reach for Control, MATCH
Keywords
Asthma management, adolescents

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reach for ControlBehavioural

    Also called RFC

    In Phase 1 (weeks 1-4), the CHW conducts an initial intake and then completes a comprehensive functional analysis (FA) of behavior to determine the causes of poor asthma management for each youth regarding asthma management. In Phase 2 (weeks 5-20) is a treatment phase and consists of a combination of mandatory cognitive-behavioral skills training (CBST) modules (received by all families) and flexible CBST modules chosen and individualized based on the results of the Phase 1 FA. This includes but not limited to In-vivo Asthma Skills Training, Improving Family Communication and Behavioral Contracting. Phase 3 (weeks 21-24) involves termination planning and relapse prevention

  • MATCHBehavioural

    Managing Asthma Through Case Management in Home (MATCH) is the current intervention provided by WCHAP to youth with poorly controlled asthma and their families.

Study groups in NCT03317977
Study groupRoleWhat they receive
Reach for ControlExperimentalReach For Control is a multi-component, home-based family therapy that targets the multiple causes of poor adolescent asthma management across individual, family and community systems.
Receives: Behavioral: Reach for Control
Michigan MATCHActive comparatorProgram endorsed by the State of Michigan for treatment of poorly controlled asthma.
Receives: Behavioral: MATCH

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Emergency Department Visits

    Emergency department visits will be obtained from electronic medical records

    Measured: Change from Baseline at 6 months, 12 months, and 18 months

Secondary outcomes (2)
  1. Family Asthma Management System Scale

    Identifies family strengths and weaknesses in the management of pediatric asthma across a variety of domains. This is a semi-structured interview that is rated on seven to nine 9-point subscales with higher scores indicating better management. The rating manual provides elaboration and brief examples at key anchor points for each rating scale. A FAMSS summary score is computed for each family by taking a mean across all subscales.

    Measured: Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months

  2. Asthma Symptom Frequency

    Self report assessing wheezing, nighttime symptoms, speech limitations and activity limitations.

    Measured: Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2017
  2. Study start1 Feb 2018
  3. Primary completion8 Aug 2023
  4. Study completion8 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03317977
Sponsor's protocol ID
071217MP4E
Other IDs
R01HL138633-01A1
Status last verified
Apr 2024
First submitted
18 Oct 2017
Last updated
4 Apr 2024
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be made available at the end of the study through presentations at scientific conferences and publications in peer-reviewed scientific journals. All final peer-reviewed manuscripts that result from the study will be submitted to PubMed Central. In addition, final dataset from the trial will be shared. Identifiers will be removed from the data prior to any release of the dataset.

Questions about this trial

What is this clinical trial studying?

A study testing MATCH in people with Asthma in Children, run by Wayne State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Apr 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Emergency Department Visits (time frame: Change from Baseline at 6 months, 12 months, and 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in